Deleterious effect of ciprofloxacin on Rickettsia conorii-infected cells is linked to toxin-antitoxin module up-regulation

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 7, 2012, Pages 1677-1682

  Botelho nevers, Elisabeth ^a   Edouard, Sophie ^a   Leroy, Quentin ^a   Raoult, Didier ^a  

^a AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

Addiction module; Doxycycline; Fluoroquinolones; Host; Rickettsiae

Indexed keywords

BACTERIAL PROTEIN; CHAPERONIN; CIPROFLOXACIN; DOXYCYCLINE; MESSENGER RNA; UNCLASSIFIED DRUG; VAPB PROTEIN; VAPC PROTEIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; IN VITRO STUDY; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; RICKETTSIA CONORII; UPREGULATION;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TOXINS; BACTERIOLOGICAL TECHNIQUES; BOUTONNEUSE FEVER; CELL CULTURE TECHNIQUES; CIPROFLOXACIN; DNA-BINDING PROTEINS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MEMBRANE GLYCOPROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; RICKETTSIA CONORII; RICKETTSIA FELIS; TETRACYCLINE; UP-REGULATION;

EID: 84862669195     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks089     Document Type: Article

References (29)

1. Levine C, Hiasa H, Marians KJ. DNA gyrase and topoisomerase IV: biochemical activities, physiological roles during chromosome replication, and drug sensitivities. Biochim Biophys Acta 1998; 1400: 29-43.
2. Rolain JM, Maurin M, Vestris G et al. In vitro susceptibilities of 27 rickettsiae to 13 antimicrobials. Antimicrob Agents Chemother 1998; 42: 1537-41.
3. Raoult D, Gallais H, De Micco P et al. Ciprofloxacin therapy for Mediterranean spotted fever. Antimicrob Agents Chemother 1986; 30: 606-7.
4. Ruiz Beltran R, Herrero Herrero JI. Evaluation of ciprofloxacin and doxycycline in the treatment of Mediterranean spotted fever. Eur J Clin Microbiol Infect Dis 1992; 11: 427-31.
5. Gudiol F, Pallares R, Carratala J et al. Randomized double-blind evaluation of ciprofloxacin and doxycycline for Mediterranean spotted fever. Antimicrob Agents Chemother 1989; 33: 987-8.
6. Laferl H, Fournier PE, Seiberl G et al. Murine typhus poorly responsive to ciprofloxacin: a case report. J Travel Med 2002; 9: 103-4.
7. Zanetti G, Francioli P, Tagan D et al. Imported epidemic typhus. Lancet 1998; 352: 1709.
8. Tantibhedhyangkul W, Angelakis E, Tongyoo N et al. Intrinsic fluoroquinolone resistance in Orientia tsutsugamushi. Int J Antimicrob Agents 2010; 35: 338-41.
9. Rovery C, Raoult D. Mediterranean spotted fever. Infect Dis Clin North Am 2008; 22: 515-30, ix.
10. Botelho-Nevers E, Rovery C, Richet H et al. Analysis of risk factors for malignant Mediterranean spotted fever indicates that fluoroquinolone treatment has a deleterious effect. J Antimicrob Chemother 2011; 66: 1821-30.
11. Hayes F. Toxins-antitoxins: plasmid maintenance, programmed cell death, and cell cycle arrest. Science 2003; 301: 1496-9.
12. Georgiades K, Raoult D. Genomes of the most dangerous epidemic bacteria have a virulence repertoire characterized by fewer genes but more toxin-antitoxin modules. PLoS One 2011; 6: e17962.
13. Goulard C, Langrand S, Carniel E et al. The Yersinia pestis chromosome encodes active addiction toxins. J Bacteriol 2010; 192: 3669-77.
14. Yamamoto TA, Gerdes K, Tunnacliffe A. Bacterial toxin RelE induces apoptosis in human cells. FEBS Lett 2002; 519: 191-4.
15. Kristoffersen P, Jensen GB, Gerdes K et al. Bacterial toxin-antitoxin gene system as containment control in yeast cells. Appl Environ Microbiol 2000; 66: 5524-6.
16. Pandey DP, Gerdes K. Toxin-antitoxin loci are highly abundant in free-living but lost from host-associated prokaryotes. Nucleic Acids Res 2005; 33: 966-76.
17. Goerke C, Koller J, Wolz C. Ciprofloxacin and trimethoprim cause phage induction and virulence modulation in Staphylococcus aureus. Antimicrob Agents Chemother 2006; 50: 171-7.
18. Zhang X, McDaniel AD, Wolf LE et al. Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J Infect Dis 2000; 181: 664-70.
19. Adams DA, Riggs MM, Donskey CJ. Effect of fluoroquinolone treatment on growth of and toxin production by epidemic and nonepidemic Clostridium difficile strains in the cecal contents of mice. Antimicrob Agents Chemother 2007; 51: 2674-8.
20. Kolodkin-Gal I, Engelberg-Kulka H. Induction of Escherichia coli chromosomal mazEF by stressful conditions causes an irreversible loss of viability. J Bacteriol 2006; 188: 3420-3.
21. Botelho-Nevers E, Rolain JM, Espinosa L et al. Statins limit Rickettsia conorii infection in cells. Int J Antimicrob Agents 2008; 32: 344-8.
22. Raoult D, Roussellier P, Vestris G et al. In vitro antibiotic susceptibility of Rickettsia rickettsii and Rickettsia conorii: plaque assay and microplaque colorimetric assay. J Infect Dis 1987; 155: 1059-62.
23. Renesto P, Rovery C, Schrenzel J et al. Rickettsia conorii transcriptional response within inoculation eschar. PLoS One 2008; 3: e3681.
24. Dumitrescu O, Badiou C, Bes M et al. Effect of antibiotics, alone and in combination, on Panton-Valentine leukocidin production by a Staphylococcus aureus reference strain. Clin Microbiol Infect 2008; 14: 384-8.
25. Ogata H, Audic S, Renesto-Audiffren P et al. Mechanisms of evolution in Rickettsia conorii and R. prowazekii. Science 2001; 293: 2093-8.
26. Ogata H, Robert C, Audic S et al. Rickettsia felis, from culture to genome sequencing. Ann N Y Acad Sci 2005; 1063: 26-34.
27. Christensen SK, Mikkelsen M, Pedersen K et al. RelE, a global inhibitor of translation, is activated during nutritional stress. Proc Natl Acad Sci USA 2001; 98: 14328-33.
28. Nieto C, Sadowy E, de la Campa AG et al. The relBE2Spn toxin-antitoxin system of Streptococcus pneumoniae: role in antibiotic tolerance and functional conservation in clinical isolates. PLoS One 2010; 5: e11289.
29. Audoly G, Vincentelli R, Edouard S et al. Effect of rickettsial toxin VapC on its eukaryotic host. PLoS One 2011; 6: e26528.